Chairman: Jami Taylor, Global Policy Leader for the Janssen Diagnostics and J&J Designate for EPEMED Board Member
Vice Chair: Mara G. Aspinall, President and CEO of Ventana and EPEMED Vice President
Personalised medicine will overhaul therapy and prevention and opens a new avenue for modern medicine. There are now concrete cases which demonstrate the potential of this approach in oncology. There is also evidence for the impact of personalized medicine in other fields such as inflammatory diseases and transplantation. Moreover, one can see the growing impact of this approach in infectiology and nutrition.
Personalised medicine has introduced a new mode of thinking with major impacts on the care and prevention organization as well as good clinical practices, ethics etc.. Thus, it implies to educate and train medical doctors, scientists and regulatory agencies, patient associations, as well as politics to this new concept.
In this context, the education committee of EPEMED should focus on the followings:
For more details, please contact Jami Taylor at email@example.com